Innovative Medicines Initiative

About IMI

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safe medicines for patients.IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA. Read more

Ebola+ Programme

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. The Ebola+ programme exemplifies how such multi-faceted collaborative efforts can have a stronger impact than any single player could alone. IMI2 offers a unique opportunity to complement the ongoing European and international efforts against Ebola.

Read more

From Twitter

RT @kuiper_em: Antibiotics: When the drugs don’t work @EFPIA https://t.co/WoT0B0GBv9 via @TheEconomist about 10 hours ago by EFPIA
RT @IpsenGroup: Industry - HCPs relationship: A new era of transparency https://t.co/e6fFNjmbnr @EFPIA #pharmadisclosure https://t.co/RmEuB… about 10 hours ago by EFPIA